Hepatitis B Virus Subtype Adw2 Hbsag Surface Protein Antigen: Side Effects, Uses & Monitoring

ENGERIX-B is indicated for immunization against infection caused by all known subtypes of hepatitis B virus.

Data source
FDA labeling via NIH DailyMed (label 4d930f24…)
Label version
current
Last reviewed
2026
Side effects

Reported adverse reactions

Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.

No structured frequency data available in current labeling. Consult the official label.

Uses

Labeled uses (from FDA prescribing information)

ENGERIX-B is indicated for immunization against infection caused by all known subtypes of hepatitis B virus. As hepatitis D (caused by the delta virus) does not occur in the absence of hepatitis B infection, it can be expected that hepatitis D will also be prevented by ENGERIX-B vaccination. ENGERIX-B will not prevent hepatitis caused by other agents, such as hepatitis A, C, and E viruses, or other pathogens known to infect the liver. Immunization is recommended in persons of all ages, especially those who are, or will be, at increased risk of exposure to hepatitis B virus,1 for example: Infants, Including Those Born of HBsAg-Positive Mothers (See DOSAGE AND ADMINISTRATION.) Adolescents (See CLINICAL PHARMACOLOGY.) Healthcare Personnel: Dentists and oral surgeons. Dental, medical, and nursing students. Physicians, surgeons, and podiatrists. Nurses. Paramedical and ambulance personnel and custodial staff who may be exposed to the virus via blood or other patient specimens. Dental hygienists and dental nurses. Laboratory and blood bank personnel handling blood, blood products, and other patient specimens. Hospital cleaning staff who handle waste. Selected Patients and Patient Contact…

Related conditions

Conditions associated with Hepatitis B Virus Subtype Adw2 Hbsag Surface Protein Antigen in labeling

FAQ

Frequently Asked Questions

What is Hepatitis B Virus Subtype Adw2 Hbsag Surface Protein Antigen used for?

FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.

What are the most commonly reported side effects of Hepatitis B Virus Subtype Adw2 Hbsag Surface Protein Antigen?

Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.

Does Hepatitis B Virus Subtype Adw2 Hbsag Surface Protein Antigen require lab monitoring?

Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Hepatitis B Virus Subtype Adw2 Hbsag Surface Protein Antigen.

Where does this information come from?

All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.

Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.

Educational content only: The information on Symptom Database.com is for educational purposes and is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Read our full disclaimer.